Both LSUHS and AHA are creating change working together to help young adults uncover their potential to find their path today through commitment to develop a robust pipeline of innovators who will develop the research, technology and innovations that will eliminate heart disease and ensure health equity in our communities.
The Center for Cardiovascular Diseases and Sciences (CCDS) is one of four Centers of Excellence on the LSU Health Shreveport campus. Cardiovascular disease research represents a considerable strength of the LSU Health Shreveport campus, with CCDS faculty receiving a sizable portion of the extramural funding to LSU Health Shreveport. In addition, the CCDS provides an excellent environment to promote trainee and faculty development.
Our NIH-funded Cardiovascular Undergraduate Research Initiative fOr Underrepresented Students (CURIOUS) program provides minority college students with hands-on training in cardiovascular research and exposure to a variety of science career options at LSU Health Shreveport. The intramural Predoctoral and Postdoctoral Fellowships couple with an NIH-funded Multidisciplinary Training in Cardiovascular Pathophysiology (MTCP) T32 Program to provide an excellent training environment to prepare trainees for careers in cardiovascular biomedical research. The NIH Center of Biomedical Research Excellence (COBRE) in Redox Biology and Cardiovascular Disease provides significant funding to early career CCDS faculty seeking their first R01 award. In addition, the CCDS provides a variety of intramural research grants for training, project development, and collaborative research opportunities. Together with the COBRE grant, the CCDS houses multiple state-of-the-art core facilities, such as the Animal Phenotyping and Histology Core, the Redox Molecular Signaling Core, the Surgical Models Core, the Virus Production Core, and the Electrophysiology Core. To enhance cardiovascular care in the local community, the CCDS supports a variety of cardiovascular clinical trials for new devices and drugs, especially for the treatment of acute coronary syndrome, heart failure, and cardiomyopathy. In addition, the CCDS provides continuing medical education for local physicians through our annual ArkLaTex Cardiology Conference and hosts an annual Heart Health Day to provide the local community with free health screenings, physician consultations, and educational activities for adults and children.
Patch.com - "The CURIOUS program is such a great experience for our students as it allows them to think critically and systematically about science, thus creating new knowledge," said Dr. Scott Chirhart, professor of biology at Centenary. "It's science in action."
PRNewswire — JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the appointment of Nicholas E. Goeders, Ph.D. to its Scientific Advisory Board (SAB). Dr. Goeders is considered one of the world’s leaders on the role of stress in drug addiction.
The rise in the prevalence of Alzheimer’s disease (AD) is becoming a national health crisis, identifying and treating its underlying causes is a critical health challenge. A team of scientists and clinicians at LSUHS had their groundbreaking findings published in the prestigious “Alzheimer’s & Dementia, The Journal of the Alzheimer’s Association”.
People who start using substances at a younger age have worse health outcomes over the long term, which requires “a nationwide education campaign on the potential long-term damage being done to the cardiovascular system in patients with substance use disorders,” writes Dr. Anthony Orr, Director of Center of Excellence for Cardiovascular Diseases and Sciences at LSUHS.